Pfizer Patents – Insights & Stats (Updated 2023)

Pfizer has a total of 88893 patents globally, out of which 23509 have been granted. Of these 88893 patents, more than 20% patents are active. United States of America is where Pfizer has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Pfizer.

Pfizer was founded in the year 1849. The Company operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices and consumer healthcare products for oncology, inflammation, cardiovascular and other therapeutic areas.

Do read about some of the most popular patents of Pfizer which have been covered by us in this article and also you can find Pfizer patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pfizer patent portfolio.

How many patents does the founder and the CEO of Pfizer have?

The founder Charles Pfizer has 0 patent and Charles F. Erhart has 0 patent and CEO Albert Bourla has 0 patent.

How many patents does Pfizer have?

Pfizer has a total of 88893 patents globally. These patents belong to 12785 unique patent families. Out of 88893 patents, 18413 patents are active.

How Many Patents did Pfizer File Every Year?

Pfizer Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPfizer Applications FiledPfizer Patents Granted
2023294729
2022704829
20211554954
2020945
2019864
2018506
20178811013
20161410821
20151815809
20141396228
20131620838
20121717894

Which Pfizer Drug Patents are Expiring in the Next 10 Years?

The patent no. US8420650B2 which is expiring in Jul, 2029, describes changing in poly(ADP-ribose)polymerase (PARP) activity to treat or prevent diseases related to PARP. This involves giving a subject a therapeutic amount of compounds represented by Formula (I) and Formula (II), along with ionizing radiation, chemotherapy, or both.

Given below is the list of few drugs patented by Pfizer accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.

Drug NamePatent NumberPatent TitlePatent Expiration
TalzennaUS8420650B2Dihydropyridophthalazinone Inhibitors…Jul, 2029
ToviazUS7807715B2Pharmaceutical Compositions Compr…Jun, 2027
VizimproUS10596162B2Method For Treating Gefitinib…Feb, 2026
VyndaqelUS7214696B2Compositions And Methods For…Dec, 2024
Nurtec OdtUS11083724B2Rimegepant For CGRP Related Dis…Mar, 2039

How many Pfizer patents are Alive/Dead?

Pfizer Patent Portfolio

 How Many Patents did Pfizer File in Different Countries?

Pfizer Worldwide Patent Filing

Countries in which Pfizer Filed Patents

CountryPatents
United States Of America8181
Japan5474
Europe5394
Mexico3765
Australia3724
Canada3104
Brazil2718
China2628
India2625
Hong Kong (S.A.R.)2383
Korea (South)2290
Germany2076
Taiwan2062
Argentina1965
Singapore1902
Austria1886
Spain1734
South Africa1652
Israel1619
New Zealand1382
Denmark1277
Chile1216
Malaysia1181
Indonesia1088
Portugal1087
Norway1059
Poland1016
Russia871
Viet Nam856
Peru797
Slovenia722
Tunisia701
Costa Rica675
Eurasia658
Philippines633
Hungary584
Morocco570
Africa558
Uruguay531
Slovakia511
Colombia506
Ecuador465
Malta437
Panama433
Dominican Republic402
Estonia401
Croatia386
Ukraine379
Saudi Arabia355
Mongolia311
Czech Republic293
Serbia275
Cyprus274
Georgia274
Iceland247
Netherlands243
Thailand238
Bulgaria204
United Kingdom203
Yugoslavia/Serbia and Montenegro199
El Salvador183
Uzbekistan165
Macao165
Cuba162
Italy148
Finland141
Nicaragua128
Africa121
Honduras106
Egypt98
Guatemala87
Algeria76
Turkey75
Brunei75
Albania73
Lithuania60
Montenegro59
Paraguay58
Bolivia52
Gulf Cooperation Council47
Pakistan45
Bangladesh33
Ireland32
Romania29
Luxembourg25
Lebanon24
Republic of Moldova22
San Marino15
Belarus15
Kenya14
Former Yugoslav Republic of Macedonia11
Belgium11
Sweden11
United Arab Emirates10
Switzerland8
Latvia8
France7
Trinidad and Tobago7
Rwanda6
Greece5
Jordan4
Belize3
Botswana1
Brunei1
Kazakhstan1
Tajikistan1

Where are Research Centres of Pfizer Patents Located?

R&D Centers of Pfizer

10 Best Pfizer Patents

US20040167572A1 is the most popular patent in the Pfizer portfolio. It has received 1728 citations so far from companies like Tyco Healthcare, Boston Scientific Scimed and Atrium Medical Corporation.

Below is the list of 10 most cited patents of Pfizer:

Publication NumberCitation Count
US20040167572A11728
US6534055B11408
US6682736B11208
US7144575B21111
WO2004056875A1952
WO2011143545A1908
US6808710B1847
WO2003077914A1718
WO2004056786A2716
US6603008B1592

How many inventions of other companies were rejected due to Pfizer patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Pfizer invention. They couldn’t because Pfizer had protected those before them.

Examiners at the USPTO referred 1722 Pfizer patents in 7108 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Pfizer patent portfolio are Protia, Wyeth and Array Biopharma.

List of the Companies whose Patents were rejected citing Pfizer –

CompanyNumber of Patent Applications that faced Rejection Citing Pfizer PatentsNumber of Rejections (102 & 103)
Protia4558
Wyeth35100
Array Biopharma3567
Genentech3266
Merck Sharp & Dohme2770
Novartis2543
Sanofi-Aventis Deutschland2363
Arena Pharmaceuticals2335
Glaxosmithkline Biologicals2234
Amgen2163

Count of 102 and 103 Type Rejections based on Pfizer Patents

 Top Pfizer Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US6603008B1153
US20040131552A130
US20100068285A116
US20070286822A116
US20080055154A114
US20070135908A114
US20080233197A113
US20040265230A113
US20050214383A112
US20040133002A112
US20030144220A111
US7401713B210
US20070228073A110
US20080051399A110
US20050004663A110

What Percentage of Pfizer US Patent Applications were Granted?

Pfizer (Excluding its subsidiaries) has filed 4882 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2269 have been granted leading to a grant rate of 70.6%.

Below are the key stats of Pfizer patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Pfizer?

Law FirmTotal ApplicationsSuccess Rate
Pfizer Inc166161.16%
Gregg C Benson57964.61%
Peter C Richardson41881.94%
Paul H Ginsburg23371.31%
Charles J Knuth16574.55%
Zoetis11487.61%
Johnson & Johnson8071.43%
Dr Peter C Richardson7095.92%
Ronald S Courtney58100.00%
Chernoff Vilhauer Mcclung & Stenzel5556.52%

EXCLUSIVE INSIGHTS COMING SOON!

What are Pfizer’s key innovation segments?

What Technologies are Covered by Pfizer?

The chart below distributes patents filed by Pfizer in different countries on the basis of the technology protected in patents. It also represents the markets where Pfizer thinks it’s important to protect particular technology inventions.

R&D Focus: How Pfizer search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pfizer?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.